Literature DB >> 19010791

Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations.

Bérénice A Benayoun1, Frank Batista, Jana Auer, Aurélie Dipietromaria, David L'Hôte, Elfride De Baere, Reiner A Veitia.   

Abstract

FOXL2 is a forkhead transcription factor, essential for ovarian function, whose mutations are responsible for the blepharophimosis syndrome, characterized by craniofacial defects, often associated with premature ovarian failure. Here, we show that cell stress upregulates FOXL2 expression in an ovarian granulosa cell model. Increased FOXL2 transcription might be mediated at least partly by self-activation. Moreover, using 2D-western blot, we show that the response of FOXL2 to stress correlates with a dramatic remodeling of its post-translational modification profile. Upon oxidative stress, we observe an increased recruitment of FOXL2 to several stress-response promoters, notably that of the mitochondrial manganese superoxide dismutase (MnSOD). Using several reporter systems, we show that FOXL2 transactivation is enhanced in this context. Models predict that gene upregulation in response to a signal should eventually be counterbalanced to restore the initial steady state. In line with this, we find that FOXL2 activity is repressed by the SIRT1 deacetylase. Interestingly, we demonstrate that SIRT1 transcription is, in turn, directly upregulated by FOXL2, which closes a negative-feedback loop. The regulatory relationship between FOXL2 and SIRT1 prompted us the test action of nicotinamide, an inhibitor of sirtuins, on FoxL2 expression/activity. According to our expectations, nicotinamide treatment increases FoxL2 transcription. Finally, we show that 11 disease-causing mutations in the ORF of FOXL2 induce aberrant regulation of FOXL2 and/or regulation of the FOXL2 stress-response target gene MnSOD. Taken together, our results establish that FOXL2 is an actor of the stress response and provide new insights into the pathogenic consequences of FOXL2 mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010791     DOI: 10.1093/hmg/ddn389

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  22 in total

1.  Notch gain of function in mouse periocular mesenchyme downregulates FoxL2 and impairs eyelid levator muscle formation, leading to congenital blepharophimosis.

Authors:  Yujin Zhang; Winston W-Y Kao; Emanuele Pelosi; David Schlessinger; Chia-Yang Liu
Journal:  J Cell Sci       Date:  2011-07-05       Impact factor: 5.285

2.  Activity-dependent neuroprotective protein modulates its own gene expression.

Authors:  Moutasem S Aboonq; Sylvia A Vasiliou; Kate Haddley; John P Quinn; Vivien J Bubb
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

Review 3.  Minireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology.

Authors:  Margareta D Pisarska; Gillian Barlow; Fang-Ting Kuo
Journal:  Endocrinology       Date:  2011-01-19       Impact factor: 4.736

4.  Microarray analysis of Foxl2 mediated gene regulation in the mouse ovary derived KK1 granulosa cell line: Over-expression of Foxl2 leads to activation of the gonadotropin releasing hormone receptor gene promoter.

Authors:  Jean M Escudero; Jodi L Haller; Colin M Clay; Kenneth W Escudero
Journal:  J Ovarian Res       Date:  2010-02-18       Impact factor: 4.234

5.  Regulation of UNC-130/FOXD-mediated mesodermal patterning in C. elegans.

Authors:  Rossio K Kersey; Thomas M Brodigan; Tetsunari Fukushige; Michael W Krause
Journal:  Dev Biol       Date:  2016-06-21       Impact factor: 3.582

6.  Human forkhead L2 represses key genes in granulosa cell differentiation including aromatase, P450scc, and cyclin D2.

Authors:  Ikuko K Bentsi-Barnes; Fang-Ting Kuo; Gillian M Barlow; Margareta D Pisarska
Journal:  Fertil Steril       Date:  2009-11-14       Impact factor: 7.329

7.  A novel FOXL2 mutation in two infertile patients with blepharophimosis-ptosis-epicanthus inversus syndrome.

Authors:  Jingmei Hu; Hanni Ke; Wei Luo; Yajuan Yang; Hongli Liu; Guangyu Li; Yingying Qin; Jinlong Ma; Shidou Zhao
Journal:  J Assist Reprod Genet       Date:  2019-12-10       Impact factor: 3.412

8.  Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).

Authors:  Bérénice A Benayoun; Sandrine Caburet; Aurélie Dipietromaria; Adrien Georges; Barbara D'Haene; P J Eswari Pandaranayaka; David L'Hôte; Anne-Laure Todeschini; Sankaran Krishnaswamy; Marc Fellous; Elfride De Baere; Reiner A Veitia
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

9.  The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.

Authors:  Kasmintan A Schrader; Bella Gorbatcheva; Janine Senz; Alireza Heravi-Moussavi; Nataliya Melnyk; Clara Salamanca; Sarah Maines-Bandiera; Susanna L Cooke; Peter Leung; James D Brenton; C Blake Gilks; John Monahan; David G Huntsman
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

Review 10.  SIRT1, is it a tumor promoter or tumor suppressor?

Authors:  Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2009-01-21       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.